NCT00867399View on ClinicalTrials.gov

A Safety and Tolerability Study of ABT-126 in Elderly

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

May 31, 2009

Conditions
Alzheimer's Disease
Interventions
DRUG

ABT-126

See arm for details

Trial Locations (1)

32809

Site Reference ID/Investigator# 17283, Orlando

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00867399 - A Safety and Tolerability Study of ABT-126 in Elderly | Biotech Hunter | Biotech Hunter